Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine for Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer
NCT06459193Phase 2Completed
- Sponsor
- Minia University
- Start
- Jun 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trimetazidine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Minia University. Started Jun 2024; status: completed.
02
Drugs
trimetazidine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT06459193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06459193.